Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9

Paclitaxel has been widely used in the treatment of breast cancer. However, the development of drug resistance often increases the failure of chemotherapy. Growing evidence has reported the significant role of microRNAs (miRs) in drug resistance. The present study identified that miR-24 was signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Jian-Ping, Yang, Liu, Tang, Jun-Wei, Sun, Peng, Hu, Qing, Qin, Jian-Wei, Xu, Xiao-Ming, Sun, Bei-Cheng, Tang, Jin-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104208/
https://www.ncbi.nlm.nih.gov/pubmed/27895747
http://dx.doi.org/10.3892/ol.2016.5139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104208/
https://www.ncbi.nlm.nih.gov/pubmed/27895747
http://dx.doi.org/10.3892/ol.2016.5139

Ejemplares similares